- PDLI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
PDL Biopharma (PDLI) 10-Q/A2012 Q2 Quarterly report (amended)
Filed: 24 May 13, 12:00am
Date: | May 23, 2013 | |
/s/ John P. McLaughlin | ||
John P. McLaughlin President and Chief Executive Officer (Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.